retatrutide weight loss trials results Results: 28.3% Data Mazdutide vs retatrutide: dual agonist
Description
One ice pack is the bare minimum for cold-chain shipping, but the under-24-hour transit window meant the freeze held easily
Weight management and health gain In the most recent trial, retatrutide-driven weight loss was accompanied by other quality-of-life improvements
Varning: Alla doser som anges i kllor r fr forsknings- eller experimentell anvndning och inte godknda medicinska riktlinjer
Who May Benefit from This Treatment Patients with MASLD, MASH, obesity with confirmed hepatic steatosis, or type 2 diabetes with liver fat accumulation represent the most likely future candidates, subject to regulatory approval and individual clinical assessment
Figure 4 illustrates some of the findings
Diabetes Obes Metab 2014;16:410e7
